Use of 5-fluorocytosine in patients with impaired renal function
- PMID: 4749757
- PMCID: PMC1587832
- DOI: 10.1136/bmj.4.5889.382
Use of 5-fluorocytosine in patients with impaired renal function
Abstract
The plasma level and elimination of 5-fluorocytosine (5-FC) was measured in normal subjects and patients with impaired renal function. Prolongation of the half-life of the drug in renal failure has been confirmed. Renal clearance of 5-FC was about 75% of the creatinine clearance and a corresponding modification of drug dosage should be made in patients with renal insufficiency.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources